Thursday, The Beachbody Company Inc (NYSE:BODI) announced a strategic partnership with Dr. B, a telehealth provider that offers $15 online consultations for common conditions in all 50 U.S. states.
BETHESDA, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Elme Communities (the "Company") (NYSE:ELME), a multifamily REIT with communities in the Washington, DC metro area and the Atlanta metro area, reported financial and operating results today…
MONROE, Mich., May 01, 2024 (GLOBE NEWSWIRE) -- La-Z-Boy Incorporated (NYSE:LZB), a global leader in the manufacture and retail of residential furniture, today declared a quarterly cash dividend on the company's common stock of $0.20 per…
Since founding Freshworks in 2010, Mathrubootham has transformed Freshworks from a fledgling startup in Chennai into a leading SaaS company headquartered in San Mateo, with products that make it easy for every business to delight their…
The Federal Trade Commission (FTC) is intensifying its efforts to challenge numerous pharmaceutical patent listings, aiming to facilitate the availability of more affordable alternatives to brand-name drugs, including blockbusters like…
"We are very pleased to be delivering another increase in our dividend, which represents the Company's seventh consecutive semiannual increase. We maintain a strong balance sheet, solid capital position, and diversified funding sources,…
Additionally, Enact announced that its Board of Directors authorized a new share repurchase program under which the company may purchase up to $250 million of its common stock. The new share repurchase authorization is in addition to the…
GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced the next phase of its new operational plan that consolidates operations, closes several manufacturing facilities, and restructures its…
With the race to the White House heating up — and election polls showing President Joe Biden and twice-impeached former President Donald Trump almost neck and neck — another poll by the Pew Research Center showed that a staggering 88% of…
DateFirmActionFromTo Feb 2022JefferiesDowngradesBuyHold Jan 2022Odeon CapitalUpgradesHoldBuy Jan 2022Keefe, Bruyette & WoodsDowngradesOutperformMarket Perform
DateFirmActionFromTo Feb 2022Morgan StanleyDowngradesOverweightEqual-Weight Feb 2022Deutsche BankMaintainsHold Feb 2022Wells FargoMaintainsEqual-Weight
DateFirmActionFromTo Feb 2022Evercore ISI GroupUpgradesIn-LineOutperform Jan 2022B of A SecuritiesDowngradesBuyNeutral Dec 2021Goldman SachsDowngradesBuyNeutral
Cannara Biotech Inc. (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0) announced its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024.